HSBA:LSEHSBC Holdings Plc Analysis
Data as of 2026-06-12 - not real-time
£1,321.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
HSBC shares are trading at 1321.8 GBp, positioned below the 20‑day SMA (1360) but above the 200‑day SMA (1181), suggesting a transitional bullish bias supported by an overall bullish trend direction and increasing volume. The RSI sits at 45, indicating neutral momentum, while the MACD histogram is negative, hinting at short‑term bearish pressure. Despite this, the price remains above the key support level of 1267 and well under the 52‑week high of 1416, leaving room for upside. The stock trades at a forward PE of 9.3 and a trailing PE of 14.5, both comfortably below the industry average PE of 16.6, pointing to a valuation advantage. A dividend yield of 4.3% with a payout ratio of ~61% underscores attractive income generation. Operating margins are robust at 50.7% and profit margins at 35%, while ROE of 11.6% reflects solid profitability. The balance sheet shows ample cash (≈£1.16 tn) relative to debt, mitigating solvency concerns. Volatility over the past 30 days is elevated at 33 % but the beta of 0.73 indicates lower systematic risk than the market. Recent news highlights regulatory scrutiny in Hong Kong, which could pressure Asian earnings, yet the broader market sentiment is in “Extreme Greed” territory. Upside potential is estimated around 8 % based on the upside/downside metric and analyst target median of 1474 GBp.
Overall, the combination of undervalued multiples, strong dividend, and resilient earnings supports a positive outlook, though regulatory and geopolitical factors warrant caution.
Overall, the combination of undervalued multiples, strong dividend, and resilient earnings supports a positive outlook, though regulatory and geopolitical factors warrant caution.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Price above 200‑day SMA indicating long‑term support
- Increasing volume supporting bullish momentum
- Attractive dividend yield of 4.3% with sustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued PE relative to industry peers
- Analyst median target price suggesting ~11% upside
- Strong profitability metrics and cash position
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Exposure to regulatory headwinds in Hong Kong and UK
- Stable dividend income for income‑focused investors
- Solid balance sheet but elevated geopolitical risk
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin34.98%
P/E Ratio14.5
ROE11.61%
ROA0.72%
P/B Ratio1.7
Industry P/E16.6
Technical Analysis
TrendBullish
RSI45.1
Support£1,267.20
Resistance£1,416.80
MA 20£1,360.26
MA 50£1,334.45
MA 200£1,181.61
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
Target Price£1,426.35
Upside/Downside7.91%
GradeUndervalued
TypeValue
Dividend Yield4.30%
Risk Assessment
Beta0.73
Volatility33.04%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.